Serial Number 99133147
686

Registration Progress

Application Filed
Apr 11, 2025
Under Examination
Approved for Publication
Oct 7, 2025
Published for Opposition
Oct 7, 2025
Registered

Attorney Assistance

Notice of Publication
Due: Nov 06, 2025 10 days

Trademark Image

Basic Information

Serial Number
99133147
Filing Date
April 11, 2025
Published for Opposition
October 7, 2025
Drawing Code
2

Status Summary

Current Status
Active
Status Code
686
Status Date
Oct 7, 2025
Application
Pending
Classes
042

Rights Holder

Dizal (Jiangsu) Pharmaceutical Co., Ltd.

16
Address
Room 404, 405,416, Building C, Huirong Business Plaza
26 Hefeng Road, Xinwu District
Wuxi, Jiangsu 214028
CN

Ownership History

Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Original Applicant
16
Wuxi, Jiangsu CN

Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Owner at Publication
16
Wuxi, Jiangsu CN

Legal Representation

Attorney
Jinggao LI

USPTO Deadlines

Next Deadline
10 days remaining
Notice of Publication
Due Date
November 06, 2025
Extension Available
Until December 06, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

9 events
Date Code Type Description Documents
Oct 7, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 7, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 1, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 9, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 8, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 26, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 26, 2025 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Apr 11, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 11, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Research laboratory analysis services in the field of cancer drug research, development, and production; Medical and scientific research, namely, conducting clinical trials for others; Medical research in the field of oncology; Medical research services; Medical research services in the field of cancer; Pharmaceutical research services; Providing medical research and scientific research information in the field of oncology via the Internet; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Research and development of vaccines and medicines; Scientific and technological services, namely, scientific research in the field of cancer drug research, development, and production; Scientific laboratory services; Scientific study and research in the field(s) of cancer drug research, development, and production

Additional Information

Design Mark
The mark consists of a stylized design of a backwards "S" shape that represents a double helix.

Classification

International Classes
042